The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia
Authors:
- Stacy R. DavidSDStacy R. David
- Cindy C. TaylorCTCindy C. Taylor
- Bruce J. KinonBKBruce J. Kinon
- Alan BreierABAlan Breier
- 1 September 2000
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 22 (9) , 1085-1096
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Risperidone and Associated AmenorrheaThe Journal of Clinical Psychiatry, 1999
- Prolactogenic effects of risperidone in male patients — a preliminary studyActa Psychiatrica Scandinavica, 1998
- Hyperprolactinaemia in Antipsychotic-Treated PatientsCNS Drugs, 1998
- Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placeboBiological Psychiatry, 1997
- The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrationsSchizophrenia Research, 1997
- Olanzapine versus Placebo and HaloperidolNeuropsychopharmacology, 1996
- Clozapine does not elevate serum prolactin levels in healthy menBiological Psychiatry, 1995
- Effects of the Menstrual Cycle on Dependent Variables in Mood Disorder ResearchArchives of General Psychiatry, 1994
- A STUDY OF SERUM PROLACTIN LEVELS IN SCHIZOPHRENIA: COMPARISON OF MALES AND FEMALESClinical and Experimental Pharmacology and Physiology, 1992
- Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patientsPsychopharmacology, 1989